A defined screening framework
Apply the transplant center’s approved referral-screening criteria to available chart information. Use the result to prioritize potential candidates for review.
InstaMD’s transplant eligibility solution applies deterministic rules to patient-chart evidence, helping transplant centers and referring practices identify potential referral candidates, resolve missing information and coordinate the path to evaluation.
InstaMD developed a rule-engine approach to transplant eligibility screening. The patient chart supplies the clinical evidence; the configured criteria determine the screening result. The transplant center reviews the findings and retains authority over clinical evaluation and waitlisting.
Apply the transplant center’s approved referral-screening criteria to available chart information. Use the result to prioritize potential candidates for review.
Review the chart evidence behind each finding, including dates and supporting records. Document interpretation and confirm clinically significant information before progressing a referral.
Distinguish a missing or outdated record from a criterion that is not met. Request additional information rather than treating absent evidence as an automatic clinical rejection.
Potential referral fit is not a guarantee of transplant eligibility, acceptance or waitlisting. Center clinicians review the patient’s circumstances and determine next steps.
Both pathways bring patient evidence and screening findings to the transplant center for review.
Launch the InstaMD solution within Epic using SMART on FHIR to review the patient context and apply the deterministic screening criteria to authorized chart data.
Use authorized FHIR bulk exports to review patient cohorts. Combine the clinical data with available scheduling data to identify patients with appointments in the next 30 days who may fit transplant referral criteria.
Nephrology practices, dialysis centers and other referring organizations enroll through an external-provider workflow. The transplant center approves access before the practice submits patient charts.
Approved practices can upload chart packages typically ranging from 10 to 400 pages, including files containing one or multiple patients. Patient-record separation and identity confirmation precede individual screening and referral review.
FHIR bulk export does not by itself guarantee appointment availability. The next-30-day cohort uses scheduling information from an authorized FHIR Appointment interface or another agreed scheduling source, depending on the Epic deployment and available permissions.
Use the embedded SMART on FHIR chart workflow or an approved FHIR bulk-data feed, with the required access and patient scope.
Identify patients scheduled within the next 30 days using the available scheduling source and associate their clinical chart data.
Evaluate available evidence against configured referral criteria and identify potential candidates and incomplete cases.
Center staff confirm the patient match, findings and missing information, then route the case for appropriate clinical review and referral action.
The referring practice requests access. The transplant center approves the organization and its authorized users.
The approved practice submits one or more patient charts, typically 10–400 pages, through the authorized upload workflow.
Separate multi-patient packages and verify patient identity, chart boundaries and extracted information. Keep each person’s evidence attached to the correct case.
The referring practice reviews rule-based screening results and supporting evidence alongside the transplant center.
The center requests missing records or clinical clarification through the approved secure workflow. The referring team supplies the requested information for review.
Complete the referral package and send it to the transplant center. Continue tracking requests, responses and the center’s disposition.
The transplant center reviews the referral package, chart evidence and screening findings. Incomplete cases can return to the referring team for further information.
The center may accept the referral for evaluation, request more information or decline it. Share the decision, rationale and next steps with the approved referring team.
Following the required evaluation, the center determines whether to approve or decline waitlisting, or defer a decision pending additional workup. Referral acceptance is separate from waitlist approval.
Track the case through referral review, evaluation, information requests and center-recorded waitlist status. Update the referring practice as the care pathway changes.
Providers can add medically necessary Remote Patient Monitoring (RPM) and Principal Care Management (PCM) to support eligible patients during active waitlisting. Care may be led by the referring physician outside the center’s network or by an outpatient practitioner at the transplant center, according to the agreed clinical and billing arrangement.
Use indicated connected-device measurements, such as blood pressure or weight, to support the treating practitioner’s care plan. Review concerns and coordinate follow-up through the agreed escalation pathway.
Maintain a condition-specific care plan, medication and appointment follow-up, and coordination between the referring team and transplant center.
Identify which practitioner directs each service, handles escalations and maintains the care plan. Coordinate center-based and outside-network services to prevent duplication.
Active waitlist status alone does not qualify a patient for RPM or PCM. Confirm medical necessity, consent, provider eligibility and payer requirements; review ESRD-related bundling, concurrent-service restrictions and distinct activity records.
Upload approved records, review screening results, respond to center requests and provide agreed ongoing care.
Approve external practices, define screening criteria, review referrals and determine evaluation and waitlisting decisions.
Configure access, data sources, referral criteria, secure communication and RPM/PCM responsibilities with the transplant center before rollout.